Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $425.64 million. The enterprise value is $329.84 million.
| Market Cap | 425.64M |
| Enterprise Value | 329.84M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IPSC has 180.35 million shares outstanding. The number of shares has increased by 34.10% in one year.
| Current Share Class | 180.35M |
| Shares Outstanding | 180.35M |
| Shares Change (YoY) | +34.10% |
| Shares Change (QoQ) | +121.65% |
| Owned by Insiders (%) | 3.25% |
| Owned by Institutions (%) | 46.15% |
| Float | 97.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.54 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.25, with a Debt / Equity ratio of 0.18.
| Current Ratio | 10.25 |
| Quick Ratio | 10.04 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.67% and return on invested capital (ROIC) is -23.62%.
| Return on Equity (ROE) | -42.67% |
| Return on Assets (ROA) | -22.28% |
| Return on Invested Capital (ROIC) | -23.62% |
| Return on Capital Employed (ROCE) | -36.58% |
| Weighted Average Cost of Capital (WACC) | 11.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.38M |
| Employee Count | 78 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -68,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +294.65% in the last 52 weeks. The beta is 1.56, so IPSC's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | +294.65% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 53.79 |
| Average Volume (20 Days) | 2,160,173 |
Short Selling Information
The latest short interest is 23.46 million, so 13.01% of the outstanding shares have been sold short.
| Short Interest | 23.46M |
| Short Previous Month | 15.41M |
| Short % of Shares Out | 13.01% |
| Short % of Float | 24.01% |
| Short Ratio (days to cover) | 12.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | -86.19M |
| Operating Income | -114.48M |
| Pretax Income | -107.85M |
| Net Income | -107.79M |
| EBITDA | -101.60M |
| EBIT | -114.48M |
| Earnings Per Share (EPS) | -$0.95 |
Balance Sheet
The company has $134.80 million in cash and $48.03 million in debt, with a net cash position of $86.78 million or $0.48 per share.
| Cash & Cash Equivalents | 134.80M |
| Total Debt | 48.03M |
| Net Cash | 86.78M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | 264.74M |
| Book Value Per Share | 1.47 |
| Working Capital | 125.47M |
Cash Flow
In the last 12 months, operating cash flow was -$94.52 million and capital expenditures -$957,000, giving a free cash flow of -$95.47 million.
| Operating Cash Flow | -94.52M |
| Capital Expenditures | -957,000 |
| Depreciation & Amortization | 12.88M |
| Net Borrowing | n/a |
| Free Cash Flow | -95.47M |
| FCF Per Share | -$0.53 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.10% |
| Shareholder Yield | -34.10% |
| Earnings Yield | -25.87% |
| FCF Yield | -22.92% |
Analyst Forecast
The average price target for IPSC is $4.75, which is 101.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.75 |
| Price Target Difference | 101.27% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -3.09 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.09 |
| Piotroski F-Score | 1 |